CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a minimally invasive liquid biopsy method for diagnosing liver disorders, replacing traditional liver biopsies. By analyzing cell-free DNA from blood samples, it seeks to differentiate between autoimmune hepatitis and other liver diseases based on gene activity.
The identification of the causative agent and mechanism of liver disorders is essential for effective treatment.
The diagnostic challenge is differentiating autoimmune hepatitis, drug induced liver damage, and other non-viral causes of liver disease.
Current diagnostic guidelines require in many cases liver biopsy followed by monitoring response to treatment before conclusive diagnosis.
Our objective is to replace liver biopsy in the parenchymal liver disease settings with a minimally invasive l…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
